Oncomine assay developed by thermofisher:Geneuity Adopts Thermo Fisher's Oncomine Assay
Geneuity Adopts Thermo Fisher's Oncomine Assay
2015年7月16日—BasedonThermoFisher'sIonAmpliSeqtechnology,theassayallowsdetectionofsinglenucleotidesomaticchanges,inversions,insertionsand ...。其他文章還包含有:「FDAClearsThermoFisherScientificOncomineAssayas...」、「GenexusOncology」、「OncomineAssaysforOncologyResearch」、「OncomineComprehensiveAssay」、「TargetedNext」、「ThermoFisherScientificExpandsOncominePortfoliofor...」、「ThermoFish...
查看更多 離開網站FDA Clears Thermo Fisher Scientific Oncomine Assay as ...
https://www.precisionmedicineo
The FDA first approved the test as a CDx in 2017, and it is now approved for four targeted therapies for non-small cell lung cancer and one ...
Genexus Oncology
https://www.oncomine.com
The only true end to end NGS solution for oncology biomarker profiling in clinical research: Ion Torrent Genexus System by Thermo Fisher Scientific.
Oncomine Assays for Oncology Research
https://www.thermofisher.com
Oncomine assays are multi-biomarker targeted NGS assays designed for cancer research. Analysis of multiple biomarker types—fusions, insertion/deletions ...
Oncomine Comprehensive Assay
https://www.thermofisher.com
Targeted Next
https://www.oncomine.com
Targeted and focused NGS assays for cancer research—Get more from your tumor samples with Oncomine assays and panels.
Thermo Fisher Scientific Expands Oncomine Portfolio for ...
https://www.labmanager.com
– (January 8, 2018) – Thermo Fisher Scientific has expanded its Oncomine portfolio with new assays for liquid biopsy and immuno-oncology to ...
Thermo Fisher Scientific Signs New Agreements to Expand ...
https://www.prnewswire.com
Expansion of Oncomine Dx Target Test aligns with the company's strategic plan to further develop its test as a companion diagnostic (CDx) for ...
Thermo Fisher's Oncomine Dx Target Test
https://thepathologist.com
Thermo Fisher Scientific's Jane Li explains the ever-developing tale of companion diagnostic tests in precision oncology.
Thermo Fisher's Oncomine Precision Assay granted ...
https://www.bioanalysis-zone.c
FDA grants Breakthrough Device Designation to Thermo Fisher's assay for identifying low-grade glioma patients eligible for vorasidenib.